Pinnacle Financial Partners Inc Neogenomics Inc Transaction History

Pinnacle Financial Partners Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 01, 2022	SELL	$30.49 - $48.49 $200,563 - $318,967	-6,578 Closed	0 $0
Q3 2021 Oct 26, 2021	BUY	$41.66 - $52.52 $2,749 - $3,466	66 Added 1.01%	6,578 $318,000
Q2 2021 Jul 21, 2021	BUY	$36.62 - $51.69 $8,349 - $11,785	228 Added 3.63%	6,512 $294,000
Q1 2021 Apr 19, 2021	SELL	$41.56 - $59.88 $74,766 - $107,724	-1,799 Reduced 22.26%	6,284 $303,000
Q4 2019 Feb 06, 2020	BUY	$18.96 - $29.84 $153,253 - $241,196	8,083 New	8,083 $236,000

295

125M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.06B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Pinnacle Financial Partners Inc, based on Form 13F filings with the SEC.

Stay updated on Pinnacle Financial Partners Inc with notifications on news.